A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection

Clinical trial NCT04784312 · COMPLETED

Trial details

NCT number: NCT04784312
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Staphylococcus Aureus Infection

Start date: 2021-04-16
Primary completion: 2021-08-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.